Person

John P. Wareham

Formerly Director, ResMed

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$14.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • RMD
    ResMed
    Director
    Aug 2016 – last filing Nov 2019

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 4, 2019RMDSale5,000$147.75$739K
Nov 4, 2019RMDSale5,956$148.00$881K
Nov 1, 2019RMDSale9,536$148.15$1.4M
May 24, 2019RMDSale23,629$114.00$2.7M
May 24, 2019RMDSale9,628$114.00$1.1M
May 24, 2019RMDSale11,085$113.44$1.3M
Jan 26, 2018RMDSale8,300$102.60$852K
Jan 26, 2018RMDSale17,634$102.09$1.8M
Feb 24, 2017RMDSale28,403$71.77$2.0M
Aug 8, 2016RMDSale24,390$70.32$1.7M

SEC reporting-owner ID (CIK) 1231182 · all filings on EDGAR

John P. Wareham | USBoard